The foundation to a cure for solid tumors is bigger than you can even imagine. I don't believe there is any easier way to mobilize the entire immune system against cancer than processing the tumor and using proper dendritic cells.
Now, if I'm not mistaken Argos claimed 27% Opdivo use in their trial. Let's hope it is similar or less in NWBO's trial, otherwise crossover is a real B. The FDA needs to look at this appropriately and if they don't we are gonna be eating chemo.
News 
Market Data 
Discover 
